Luciane Sussuchi da Silva

Dr. Luciane Sussuchi da Silva

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 February 2020 in Cells
Verified
Journal Article
Open access
PDF file
WMWeder Menezes
Weder Menezes
VSViviane Silva
Viviane Silva
IGIzabela Natalia Faria Gomes
Izabela Natalia Faria Gomes
MRMarcela Nunes Rosa
Marcela Nunes Rosa
MSMaria Luisa Corcoll Spina
Maria Luisa Corcoll Spina
RRRui M. Reis
Rui M. Reis
The 5’-methylthioadenosine phosphorylase (MTAP) gene is located in the chromosomal region 9p21. MTAP deletion is a frequent event in a wide variety of human cancers; however, its biological role in tumorigenesis remains unclear. The purpose of this study was to characterize the MTAP expression profile in a series of gliomas and to associate it with patients’ clinicopathological features. Moreover, we sought to evaluate, through glioma gene-edited cell lines, the biological impact of MTAP in gliomas. MTAP expression was evaluated in 507 glioma patients by immunohistochemistry (IHC), and the expression levels were associated with patients’ clinicopathological features. Furthermore, an in silico study was undertaken using genomic databases totalizing 350 samples. In glioma cell lines, MTAP was edited, and following MTAP overexpression and knockout (KO), a transcriptome analysis was performed by NanoString Pan-Cancer Pathways panel. Moreover, MTAP’s role in glioma cell proliferation, migration, and invasion was evaluated. Homozygous deletion of 9p21 locus was associated with a reduction of MTAP mRNA expression in the TCGA (The Cancer Genome Atlas) - glioblastoma dataset (p < 0.01). In addition, the loss of MTAP expression was markedly high in high-grade gliomas (46.6% of cases) determined by IHC and Western blotting (40% of evaluated cell lines). Reduced MTAP expression was associated with a better prognostic in the adult glioblastoma dataset (p < 0.001). Nine genes associated with five pathways were differentially expressed in MTAP-knockout (KO) cells, with six upregulated and three downregulated in MTAP. Analysis of cell proliferation, migration, and invasion did not show any significant differences between MTAP gene-edited and control cells. Our results integrating data from patients as well as in silico and in vitro models provide evidence towards the lack of strong biological importance of MTAP in gliomas. Despite the frequent loss of MTAP, it seems not to have a clinical impact in survival and does not act as a canonic tumor suppressor gene in gliomas.

26 October 2016 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
DCDaniele Chaves-Moreira
Daniele Chaves-Moreira
FMFabio Rogerio de Moraes
Fabio Rogerio de Moraes
ICIcaro Caruso
Icaro Caruso
OCOlga Meiri Chaim
Olga Meiri Chaim
ASAndrea Senff-Ribeiro
Andrea Senff-Ribeiro
SVSilvio Veiga
Silvio Veiga

4 January 2022 in Cells
Verified
Journal Article
Open access
PDF file
IGIzabela Natalia Faria Gomes
Izabela Natalia Faria Gomes
RSRenato J. Silva-Oliveira
Renato J. Silva-Oliveira
LSLuciane Sussuchi da Silva
Luciane Sussuchi da Silva
OMOlga Martinho
Olga Martinho
AEAdriane Evangelista
Adriane Evangelista
RRRui M. Reis
Rui M. Reis
Cetuximab is the sole anti-EGFR monoclonal antibody that is FDA approved to treat head and neck squamous cell carcinoma (HNSCC). However, no predictive biomarkers of cetuximab response are known for HNSCC. Herein, we address the molecular mechanisms underlying cetuximab resistance in an in vitro model. We established a cetuximab resistant model (FaDu), using increased cetuximab concentrations for more than eight months. The resistance and parental cells were evaluated for cell viability and functional assays. Protein expression was analyzed by Western blot and human cell surface panel by lyoplate. The mutational profile and copy number alterations (CNA) were analyzed using whole-exome sequencing (WES) and the NanoString platform. FaDu resistant clones exhibited at least two-fold higher IC50 compared to the parental cell line. WES showed relevant mutations in several cancer-related genes, and the comparative mRNA expression analysis showed 36 differentially expressed genes associated with EGFR tyrosine kinase inhibitors resistance, RAS, MAPK, and mTOR signaling. Importantly, we observed that overexpression of KRAS, RhoA, and CD44 was associated with cetuximab resistance. Protein analysis revealed EGFR phosphorylation inhibition and mTOR increase in resistant cells. Moreover, the resistant cell line demonstrated an aggressive phenotype with a significant increase in adhesion, the number of colonies, and migration rates. Overall, we identified several molecular alterations in the cetuximab resistant cell line that may constitute novel biomarkers of cetuximab response such as mTOR and RhoA overexpression. These findings indicate new strategies to overcome anti-EGFR resistance in HNSCC.

1 July 2020 in The Journal of Molecular Diagnostics
Verified
Journal Article
Closed access
LSLuciane Sussuchi da Silva
Luciane Sussuchi da Silva
BMBruna M. Mançano
Bruna M. Mançano
FPFlávia E. de Paula
Flávia E. de Paula
MRMariana B. dos Reis
Mariana B. dos Reis
GAGisele C. de Almeida
Gisele C. de Almeida
RRRui M. Reis
Rui M. Reis

28 August 2015 in Current Protein & Peptide Science
Verified
Journal Article
Closed access
PDF file
MCM.A. Coronado
M.A. Coronado
AUAnwar Ullah
Anwar Ullah
LSLuciane Sussuchi da Silva
Luciane Sussuchi da Silva
DCDaniele Chaves-Moreira
Daniele Chaves-Moreira
LVL. Vuitika
L. Vuitika
Raghuvir ArniRaghuvir Arni
Raghuvir Arni
Phospholipases D (PLDs), the major dermonecrotic factors from brown spider venoms, trigger a range of biological reactions both in vitro and in vivo. Despite their clinical relevance in loxoscelism, structural data is restricted to the apo-form of these enzymes, which has been instrumental in understanding the functional differences between the class I and II spider PLDs. The crystal structures of the native class II PLD from Loxosceles intermedia complexed with myo-inositol 1-phosphate and the inactive mutant H12A complexed with fatty acids indicate the existence of a strong ligand-dependent conformation change of the highly conserved aromatic residues, Tyr 223 and Trp225 indicating their roles in substrate binding. These results provided insights into the structural determinants for substrate recognition and binding by class II PLDs.

1 December 2019 in Future Microbiology
Verified
Journal Article
Closed access
LSLuciane Sussuchi da Silva
Luciane Sussuchi da Silva
UBUessiley R Barbosa
Uessiley R Barbosa
LSLívia Do C Silva
Lívia Do C Silva
CSCélia Ma Soares
Célia Ma Soares
MPMaristela Pereira
Maristela Pereira
RSRoosevelt Alves Da Silva
Roosevelt Alves Da Silva
Aim: To perform virtual screening of compounds based on natural products targeting isocitrate lyase of Paracoccidioides brasiliensis. Materials & methods: Homology modeling and molecular dynamics s...